Affinity Capital (Taiwan) Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 9

Professionals

  • Investments
  • 13

  • Portfolio
  • 10

  • Exits
  • 3

Exits

Affinity Capital (Taiwan) General Information

Company Description

Affinity Capital is a growth equity firm based in Taipei City, Taiwan. The firm seeks to invest in novel therapeutics, advanced medical devices, biotechnology, innovative therapies and healthcare services sectors.

Business Details

Website
www.affinity.com.tw
Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Other Investor Types
Venture Capital
Corporate Office
  • Room. 1101, 11th Floor., Number 136, Sec. 3
  • Renai Road., Daan District
  • Taipei City, 106
  • Taiwan
+886 02

Affinity Capital (Taiwan) Investments (13)

Affinity Capital (Taiwan)’s most recent investment was a with Elixiron for . The deal was made on 18-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Elixiron 18-Jun-2025 Drug Discovery Generating Revenue
Petlife Store 16-Jun-2025 Specialty Retail Generating Revenue
HanchorBio 01-Jan-2024 Drug Discovery Generating Revenue
Mingyi 01-Jan-2024 Clinics/Outpatient Services Generating Revenue
Lincotec 01-Aug-2022 PE Growth/Expansion General Purpose Semiconductors Generating Revenue
You’re viewing 5 of 13 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affinity Capital (Taiwan) Exits (3)

Affinity Capital (Taiwan) has made a total of 3 exits. Its latest exit was from HanchorBio for on 29-May-2026. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
HanchorBio 29-May-2026
BRIM Biotechnology 12-Dec-2024 IPO
You’re viewing 2 of 3 exits. Get the full list »

Affinity Capital (Taiwan) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Affinity Capital (Taiwan) FAQs

  • What is Affinity Capital (Taiwan)?

    Affinity Capital is a growth equity firm based in Taipei City, Taiwan.

  • Where is Affinity Capital (Taiwan) headquartered?

    Affinity Capital (Taiwan) is headquartered in Taipei City, Taiwan.

  • How many investments has Affinity Capital (Taiwan) made?

    Affinity Capital (Taiwan) has made 13 investments.

  • What has Affinity Capital (Taiwan) invested in?

    Affinity Capital (Taiwan) has made numerous investments in companies like Elixiron, Petlife Store, and HanchorBio within the Drug Discovery and Specialty Retail industries.

  • What has Affinity Capital (Taiwan) invested in recently?

    Affinity Capital (Taiwan)'s latest investment was on 18-Jun-2025 in Elixiron, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process